Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:43 PM
Ignite Modification Date:
2025-12-24 @ 9:43 PM
NCT ID:
NCT02024932
Eligibility Criteria:
Key Inclusion Criteria:
* Genetic diagnosis of SBMA with symptomatic muscle weakness
* Able to complete 2 minute timed walk
* Serum IGF-1 level less than or equal to 170 ng/mL
Key Exclusion Criteria:
* Medically treated diabetes mellitus or known history of hypoglycemia
* History of Bell's palsy
* Treatment with systemic steroids \> 10 mg/day (or equivalent dose); androgens or androgen reducing agents; systemic beta agonists; or other muscle anabolic drugs within the previous 3 months
* History of cancer, other than non-melanomatous skin cancer
* Retinopathy
* Papilledema Other protocol defined inclusion/exclusion criteria may apply
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT02024932
Study Brief:
Protocol Section:
NCT02024932